Skip to content
Search

Latest Stories

Steve Barclay appointed as new health secretary

Boris Johnson has picked Steve Barclay as the new health secretary following the resignation of Sajid Javid, who stepped down on July 5 after saying he had lost faith in prime minister's leadership.

Barclay -- who had served as chief of staff of the prime minister since February 2022 -- was previously a junior health minister in 2018, responsible for NHS workforce and finance, before serving as Brexit secretary, chief secretary to the Treasury, and chancellor of the duchy.


He is the fourth health secretary after Jeremy Hunt, Matt Hancock and Sajid Javid in the past five years.

In a statement on his appointment, Barclay said it was “an honor” to be take up the position, adding: "Our NHS and social care staff have showed us time and again – throughout the pandemic and beyond – what it means to work with compassion and dedication to transform lives.

"This government is investing more than ever before in our NHS and care services to beat the Covid-19 backlogs, recruit 50,000 more nurses, reform social care and ensure patients across the country can access the care they need."

Late in the evening on July 5, he tweeted:

Welcoming the new secretary of state to his role, PSNC chief executive Janet Morrison said that the PSNC would look forward to working with him, the pharmacy minister and officials at the Department of Health and Social Care "to further dialogue about the future role and funding of community pharmacy."

She added: “He [Barclay] joins the department at a critical time as the NHS continues on the long path to recovery from the Covid-19 pandemic. We see community pharmacy as being a vital element of plans for that recovery and know that we could do so much more, but only with appropriate funding."

Commenting on the appointment of Barclay, chair of RPS in England Thorrun Govind said: “This is a crucial time for the future of health and care – with continued pressures on teams, changes to NHS structures and organizations, and the need for long-term investment in the workforce.

“I hope the new health secretary will engage with pharmacy leaders about how we can make the most of our health and care workforce to support the NHS recovery, including reducing health inequalities, managing the growing cost of long-term conditions, and utilising the enhanced skills of Pharmacist Independent Prescribers.

“With a ‘refresh’ of the NHS Long-Term Plan and the Government’s workforce plan expected later this year, these must support a more ambitious approach to advancing the clinical role of pharmacists across the NHS to better meet changing patient demand, backed by investment in pharmacy education and training.

“Sajid Javid recognised the vital role of community pharmacy and the potential of a ‘Pharmacy First’ to support patient access to care. I would urge the new Health Secretary to see this through to completion."

Gareth Jones, director of corporate affairs at the National Pharmacy Association (NPA), added: “The same logic that led the previous Health Secretary to announce recently his support for a ‘pharmacy first’ approach to primary care still applies today. Community pharmacy remains well positioned, given the right investment, to support the NHS recovery and take on clinical roles in urgent care, long-term conditions, medicines optimisation and prevention.

“The NPA will of course be in contact with Steve Barclay to offer the hand of partnership for improving access, addressing health inequalities and delivering excellent patient care.

“We maintained a close and constructive dialogue with Sajid Javid and we hope that will continue with his successor.”

Barclay has been the Conservative MP for North East Cambridgeshire since 2010 and had a relatively slow start to his ministerial career until he was catapulted to a cabinet rank as Brexit secretary in November 2018, having been a 'Leave supporter' during the EU referendum.

He read history at Cambridge and spent a gap year serving in the Army with the Royal Regiment of Fusiliers. After training as a lawyer, he worked as regulator for the Financial Services Authority and later as head of anti-money laundering at Barclays Bank before becoming a politician.

Barclay is married with two children.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less